• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novavax, Inc. - Common Stock (NQ: NVAX )

    8.510 -0.130 (-1.50%)
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,475,572
    Open 8.660
    Bid (Size) 8.480 (7)
    Ask (Size) 8.500 (6)
    Prev. Close 8.640
    Today's Range 8.450 - 8.660
    52wk Range 3.532 - 23.86
    Shares Outstanding 74,484,166
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market?
    It’s not a bear market for biotech yet it just feels that way because recent trends are down and healthcare stocks are not a stabilizing force. 
    Via Talk Markets
    Topics ETFs Stocks / Equities
    Peering Into Novavax's Recent Short Interest
    Via Benzinga

    Performance

    YTD
    +69.18%
    +69.18%
    1 Month
    -8.69%
    -8.69%
    3 Month
    -35.97%
    -35.97%
    6 Month
    -39.21%
    -39.21%
    1 Year
    +68.51%
    +68.51%

    More News

    Read More
    Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
    Via Benzinga
    Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
    Via Benzinga
    Topics Supply Chain
    Exposures Supply Chain
    Earnings Scheduled For November 12, 2024
    Via Benzinga
    Earnings Outlook For Novavax
    Via Benzinga
    Looking Into Novavax's Recent Short Interest
    Via Benzinga
    How Is The Market Feeling About Novavax?
    Via Benzinga
    2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors
    Via The Motley Fool
    Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
    Via Benzinga
    Is Biotech’s Bull Run Over? Examining Election Impacts
    Via MarketBeat
    Topics ETFs Government
    Exposures Political
    Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
    Via Benzinga
    Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
    Via Investor's Business Daily
    Topics Government
    Exposures Political
    WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
    Via Benzinga
    Topics Government
    Exposures Political
    US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus
    Via Benzinga
    Topics Economy
    Exposures Economy Interest Rates
    Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
    Via Benzinga
    Topics Government
    Exposures Political
    Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls
    Via Benzinga
    Exposures Product Safety
    FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
    Via Benzinga
    Exposures Product Safety
    Smaller Cap Biotechs Are In Season: How Are We Doing?
    Via Talk Markets
    Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
    Via Benzinga
    Exposures COVID-19
    NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
    Via The Motley Fool
    This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
    Via The Motley Fool
    NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    How Bad Is This News for Novavax?
    Via The Motley Fool
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.